title: A new formulation for orally disintegrating tablets using a suspension spray-coating method.
abstract: The aim of this study was to design a new orally disintegrating tablet (ODT) that has high tablet hardness and a fast oral disintegration rate using a new preparation method. To obtain rapid disintegration granules (RDGs), a saccharide, such as trehalose, mannitol, or lactose, was spray-coated with a suspension of corn starch using a fluidized-bed granulator (suspension method). As an additional disintegrant, crospovidone, light anhydrous silicic acid, or hydroxypropyl starch was also included in the suspension. The RDGs obtained possessed extremely large surface areas, narrow particle size distribution, and numerous micro-pores. When tabletting these RDGs, it was found that the RDGs increased tablet hardness by decreasing plastic deformation and increasing the contact frequency between granules. In all tablets, a linear relationship was observed between tablet hardness and oral disintegration time. From each linear correlation line, a slope (D/H value) and an intercept (D/H(0) value) were calculated. Tablets with small D/H and D/H(0) values could disintegrate immediately in the oral cavity regardless of the tablet hardness and were considered to be appropriate for ODTs. Therefore, these values were used as key parameters to select better ODTs. Of all the RDGs prepared in this study, mannitol spray-coated with a suspension of corn starch and crospovidone (2.5:1 w/w ratio) showed most appropriate properties for ODTs; fast in vivo oral disintegration time, and high tablet hardness. In conclusion, this simple method to prepare superior formulations for new ODTs was established by spray-coating mannitol with a suspension of appropriate disintegrants.
authors.affiliation: Towa Pharmaceutical Co., Ltd., 26-7 Ichiban-Cho, Kadoma, Osaka 571-0033, Japan. y-okuda@towayakuhin.co.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Okuda
authors.forename: Y
authors.initials: Y
authors.lastname: Irisawa
authors.forename: K
authors.initials: K
authors.lastname: Okimoto
authors.forename: T
authors.initials: T
authors.lastname: Osawa
authors.forename: S
authors.initials: S
authors.lastname: Yamashita
mesh_terms: D000284:Administration, Oral; D002626:Chemistry, Pharmaceutical; D005079:Excipients / Q000737:chemistry*; D006244:Hardness; D007700:Kinetics; D007785:Lactose / Q000737:chemistry; D016014:Linear Models; D008353:Mannitol / Q000737:chemistry*; D008956:Models, Chemical; D010316:Particle Size; D016062:Porosity; D011205:Povidone / Q000737:chemistry*; D012824:Silicic Acid / Q000737:chemistry; D012995:Solubility; D013213:Starch / Q000737:chemistry*; D013229:Stearic Acids / Q000737:chemistry; D013499:Surface Properties; D013607:Tablets; D013678:Technology, Pharmaceutical / Q000379:methods*; D014199:Trehalose / Q000737:chemistry
chemical_list: D005079:Excipients; D013229:Stearic Acids; D013607:Tablets; D012824:Silicic Acid; D008353:Mannitol; C031183:stearic acid; D013213:Starch; D014199:Trehalose; D011205:Povidone; D007785:Lactose